Protocol and apparatus for determining heparin-induced thrombocytopenia
US7811792B2 · kind B2 · utility
32Cited by
0References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 27, 2009 |
| Grant date | Oct 12, 2010 |
| Priority date | — |
| Expiry date | Apr 27, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q1/56
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit determination of heparin-induced thrombocytopenia II complex (HiT II).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.